Jane Street’s PAVmed PAVM Stock Holding History

Jane Street’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-37	Closed	-$41K	–	10847
2021 Q4	$41K	Sell	37 -90	-71%	-$196K	﹤0.01%	9599
2021 Q3	$488K	Buy	127 +97	+323%	+$306K	﹤0.01%	7321
2021 Q2	$86K	Buy	+30	New	+$70.9K	﹤0.01%	9328

Other funds holding PAVM

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street's PAVM Position: Q4 2025 in Review

Jane Street sold out of PAVmed (PAVM) in Q4 2025, closing a stake of 5,077 shares — an estimated $65.6K sold.

Jane Street first reported a position in PAVM in Q2 2018 and held it in 14 quarters. The position peaked at $2.42M in Q3 2021. 28 funds tracked by Wall St. Rank hold PAVM as of Q4 2025.

Jane Street reported no remaining PAVmed position as of Q4 2025 after selling out during the quarter.
Jane Street sold 5,077 PAVmed shares in Q4 2025, an estimated $65.6K.
Jane Street first reported a position in PAVmed in Q2 2018 and held it in 14 quarters.
Jane Street's PAVmed position peaked at $2.42M in Q3 2021.
28 funds tracked by Wall St. Rank held PAVmed as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.